Selected research
Industry Research
Antacids Tablet Industry Research Report 2026
Market perspective
The global Antacids Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antacids Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antacids Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antacids Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antacids Tablet include Bausch Health, CONBA, CR SANJIU, Procter＆Gamble, Reckitt Benckiser, Reddy's Laboratories, AstraZeneca, Bayer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antacids Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antacids Tablet Market by Company
Bausch Health
CONBA
CR SANJIU
Procter＆Gamble
Reckitt Benckiser
Reddy's Laboratories
AstraZeneca
Bayer
GlaxoSmithKline
Pfizer
Johnson＆Johnson
Sanofi
Takeda Pharmaceutical
Xiuzheng Pharma
Antacids Tablet Segment by Type
Proton Pump Inhibitor
Acid Neutralizers
H2 Antagonist
Antacids Tablet Segment by Application
OTC Drug
Rx Drug
Antacids Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antacids Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antacids Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antacids Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antacids Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antacids Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antacids Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Proton Pump Inhibitor
- Acid Neutralizers
- H2 Antagonist
Applications
- OTC Drug
- Rx Drug
Companies covered
- Bausch Health
- CONBA
- CR SANJIU
- Procter＆Gamble
- Reckitt Benckiser
- Reddy's Laboratories
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Pfizer
- Johnson＆Johnson
- Sanofi
- Takeda Pharmaceutical
- Xiuzheng Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antacids Tablet Market Size (2021-2032)
- 2.2.2 Global Antacids Tablet Sales (2021-2032)
- 2.2.3 Global Antacids Tablet Market Average Price (2021-2032)
- 2.3 Antacids Tablet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Proton Pump Inhibitor
- 2.3.3 Acid Neutralizers
- 2.3.4 H2 Antagonist
- 2.4 Antacids Tablet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 OTC Drug
- 2.4.3 Rx Drug
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antacids Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antacids Tablet Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Antacids Tablet Revenue of Manufacturers (2021-2026)
- 3.4 Global Antacids Tablet Average Price by Manufacturers (2021-2026)
- 3.5 Global Antacids Tablet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antacids Tablet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antacids Tablet, Product Type & Application
- 3.8 Global Manufacturers of Antacids Tablet, Established Date
- 3.9 Global Antacids Tablet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bausch Health
- 4.1.1 Bausch Health Company Information
- 4.1.2 Bausch Health Business Overview
- 4.1.3 Bausch Health Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bausch Health Antacids Tablet Product Portfolio
- 4.1.5 Bausch Health Recent Developments
- 4.2 CONBA
- 4.2.1 CONBA Company Information
- 4.2.2 CONBA Business Overview
- 4.2.3 CONBA Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CONBA Antacids Tablet Product Portfolio
- 4.2.5 CONBA Recent Developments
- 4.3 CR SANJIU
- 4.3.1 CR SANJIU Company Information
- 4.3.2 CR SANJIU Business Overview
- 4.3.3 CR SANJIU Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CR SANJIU Antacids Tablet Product Portfolio
- 4.3.5 CR SANJIU Recent Developments
- 4.4 Procter＆Gamble
- 4.4.1 Procter＆Gamble Company Information
- 4.4.2 Procter＆Gamble Business Overview
- 4.4.3 Procter＆Gamble Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Procter＆Gamble Antacids Tablet Product Portfolio
- 4.4.5 Procter＆Gamble Recent Developments
- 4.5 Reckitt Benckiser
- 4.5.1 Reckitt Benckiser Company Information
- 4.5.2 Reckitt Benckiser Business Overview
- 4.5.3 Reckitt Benckiser Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Reckitt Benckiser Antacids Tablet Product Portfolio
- 4.5.5 Reckitt Benckiser Recent Developments
- 4.6 Reddy's Laboratories
- 4.6.1 Reddy's Laboratories Company Information
- 4.6.2 Reddy's Laboratories Business Overview
- 4.6.3 Reddy's Laboratories Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Reddy's Laboratories Antacids Tablet Product Portfolio
- 4.6.5 Reddy's Laboratories Recent Developments
- 4.7 AstraZeneca
- 4.7.1 AstraZeneca Company Information
- 4.7.2 AstraZeneca Business Overview
- 4.7.3 AstraZeneca Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 AstraZeneca Antacids Tablet Product Portfolio
- 4.7.5 AstraZeneca Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Antacids Tablet Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 GlaxoSmithKline
- 4.9.1 GlaxoSmithKline Company Information
- 4.9.2 GlaxoSmithKline Business Overview
- 4.9.3 GlaxoSmithKline Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 GlaxoSmithKline Antacids Tablet Product Portfolio
- 4.9.5 GlaxoSmithKline Recent Developments
- 4.10 Pfizer
- 4.10.1 Pfizer Company Information
- 4.10.2 Pfizer Business Overview
- 4.10.3 Pfizer Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pfizer Antacids Tablet Product Portfolio
- 4.10.5 Pfizer Recent Developments
- 4.11 Johnson＆Johnson
- 4.11.1 Johnson＆Johnson Company Information
- 4.11.2 Johnson＆Johnson Business Overview
- 4.11.3 Johnson＆Johnson Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Johnson＆Johnson Antacids Tablet Product Portfolio
- 4.11.5 Johnson＆Johnson Recent Developments
- 4.12 Sanofi
- 4.12.1 Sanofi Company Information
- 4.12.2 Sanofi Business Overview
- 4.12.3 Sanofi Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Sanofi Antacids Tablet Product Portfolio
- 4.12.5 Sanofi Recent Developments
- 4.13 Takeda Pharmaceutical
- 4.13.1 Takeda Pharmaceutical Company Information
- 4.13.2 Takeda Pharmaceutical Business Overview
- 4.13.3 Takeda Pharmaceutical Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Takeda Pharmaceutical Antacids Tablet Product Portfolio
- 4.13.5 Takeda Pharmaceutical Recent Developments
- 4.14 Xiuzheng Pharma
- 4.14.1 Xiuzheng Pharma Company Information
- 4.14.2 Xiuzheng Pharma Business Overview
- 4.14.3 Xiuzheng Pharma Antacids Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Xiuzheng Pharma Antacids Tablet Product Portfolio
- 4.14.5 Xiuzheng Pharma Recent Developments
5 Global Antacids Tablet Market Scenario by Region
- 5.1 Global Antacids Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antacids Tablet Sales by Region: 2021-2032
- 5.2.1 Global Antacids Tablet Sales by Region: 2021-2026
- 5.2.2 Global Antacids Tablet Sales by Region: 2027-2032
- 5.3 Global Antacids Tablet Revenue by Region: 2021-2032
- 5.3.1 Global Antacids Tablet Revenue by Region: 2021-2026
- 5.3.2 Global Antacids Tablet Revenue by Region: 2027-2032
- 5.4 North America Antacids Tablet Market Facts & Figures by Country
- 5.4.1 North America Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antacids Tablet Sales by Country (2021-2032)
- 5.4.3 North America Antacids Tablet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Antacids Tablet Market Facts & Figures by Country
- 5.5.1 Europe Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antacids Tablet Sales by Country (2021-2032)
- 5.5.3 Europe Antacids Tablet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Antacids Tablet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antacids Tablet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antacids Tablet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antacids Tablet Market Facts & Figures by Country
- 5.7.1 South America Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antacids Tablet Sales by Country (2021-2032)
- 5.7.3 South America Antacids Tablet Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Antacids Tablet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antacids Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antacids Tablet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antacids Tablet Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Antacids Tablet Sales by Type (2021-2032)
- 6.1.1 Global Antacids Tablet Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Antacids Tablet Sales Market Share by Type (2021-2032)
- 6.2 Global Antacids Tablet Revenue by Type (2021-2032)
- 6.2.1 Global Antacids Tablet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antacids Tablet Revenue Market Share by Type (2021-2032)
- 6.3 Global Antacids Tablet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antacids Tablet Sales by Application (2021-2032)
- 7.1.1 Global Antacids Tablet Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Antacids Tablet Sales Market Share by Application (2021-2032)
- 7.2 Global Antacids Tablet Revenue by Application (2021-2032)
- 7.2.1 Global Antacids Tablet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antacids Tablet Revenue Market Share by Application (2021-2032)
- 7.3 Global Antacids Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antacids Tablet Value Chain Analysis
- 8.1.1 Antacids Tablet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antacids Tablet Production Mode & Process
- 8.2 Antacids Tablet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antacids Tablet Distributors
- 8.2.3 Antacids Tablet Customers
9 Global Antacids Tablet Analyzing Market Dynamics
- 9.1 Antacids Tablet Industry Trends
- 9.2 Antacids Tablet Industry Drivers
- 9.3 Antacids Tablet Industry Opportunities and Challenges
- 9.4 Antacids Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst